This study is in progress, not accepting new patients
A Phase 2a of RSLV-132 in Subjects With Systemic Lupus Erythematosus (SLE)
a study on Lupus
Summary
- Eligibility
- for people ages 18-70 (full criteria)
- Location
- at La Jolla, California and other locations
- Dates
- study startedestimated completion
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Resolve Therapeutics
- ID
- NCT02660944
- Phase
- Phase 2
- Study Type
- Interventional
- Last Updated